The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-1156-2018·Announced 2018-09-05

Auro Pharmacies Recalls CoEnzyme-Q10 Injectable Due to Sterility Concerns

Auro Pharmacies is recalling 39 vials of CoEnzyme-Q10 injectable because inadequate processes and equipment failed to assure product sterility.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility for an injectable product, which aligns with the rubric criteria for Severe severity (FDA Class II with potential for significant injury).

Plain-English summary

Auro Pharmacies, Inc. is recalling 39 vials of CoEnzyme-Q10 injectable, 20 mg/mL, 10 mL Multiple Dose vial. The product was distributed nationwide in the USA. The specific lot number is 180626/3, with an expiration date of 25-Aug-18.

The recall was initiated due to a lack of assurance of sterility. The source text indicates that inadequate processes and equipment were used to assure the sterility of products intended to be sterile.

Consumers who have this specific product should stop using it and contact their healthcare provider or the recalling firm for further instructions.

The recalled product

Product
CoEnzyme-Q10 injectable, 20 mg/mL, 10 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631
Manufacturer
Auro Pharmacies, Inc.
Category
Drug — Injectable
Hazard
Affected units
39

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 180626/3
  • Exp 25-Aug-18

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 12 recalled by Auro Pharmacies, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 12 products in this recall →

Related recalls

Same manufacturer · Auro Pharmacies, Inc.

See all →

Same hazard · sterility

See all →

Similar recalls